New Interchangeable Biosimilar for Insulin Approved: What It Means for Diabetics A new biosimilar product, the first one for insulin, has been approved by the Food Read More » Surabhi Dangi-Garimella PhD August 11, 2021
Biosimilars: What is Interchangeability, Reference Product, and Why You Should Care Recently, I had a conversation with a small group of patients from the #PatientsRisingFam about Read More » Jim Sliney Jr. August 11, 2021
Patients Rising Asks: Why Are Rheumatologists Hesitant to Switch Patients to Biosimilars? Results from an online survey (Medscape.com) of board-certified U.S. rheumatologists found reluctance to switch patients Read More » Surabhi Dangi-Garimella PhD February 9, 2021
Know Your Options: Innovations in Migraine Treatment Learn about new classes of drugs to prevent and treat migraines, as well as options to reduce their frequency. Read More » Surabhi Dangi-Garimella PhD May 7, 2020
Biologics for Asthma: Fixing the Future Might biologics be the answer to the asthma problem? Read More » Jim Sliney Jr, Editor December 7, 2018
Biosimilar Medications: What Psoriasis and Psoriatic Arthritis Patients Need to Know The hottest topic now for psoriasis and psoriatic arthritis patients are the new psoriasis biosimilar treatments. Read More » Jim Sliney Jr, Editor September 7, 2017